CG Oncology Inc.
CGON | NASDAQ
$78.25
+$3.63 (+4.86%)
At close: Sep 21, 2026, 4:00 PM ET
$78.25
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Net Income | -161M | -88.04M | -48.61M | -35.44M | -12.84M |
Depreciation & Amortization | 1.45M | 32K | 17K | 15K | 10K |
Stock-Based Compensation | 26.68M | 11.4M | 1.53M | 676K | 1.11M |
Other Working Capital | 4.68M | 320K | 1.43M | 4.46M | -2.55M |
Other Non-Cash Items | -1.75M | -5.01M | -2.06M | 509K | 30K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.28M | 2.91M | 3.44M | 4.44M | -1.97M |
Operating Cash Flow | -132.35M | -78.71M | -45.68M | -29.8M | -13.65M |
Capital Expenditures | -134K | -234K | n/a | -14K | -97K |
Cash Acquisitions | -21.97M | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.07B | -1.05B | -517.61M | -55.34M | n/a |
Sales Maturities Of Investments | 844.14M | 745.41M | 396.42M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -245.82M | -300.76M | -121.2M | -55.35M | -97K |
Debt Repayment | n/a | -365K | -16.29M | n/a | 15.2M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -825K | -3.42M | n/a | n/a |
Financial Cash Flow | 153.59M | 628.28M | 87M | 119.69M | 15.45M |
Net Cash Flow | -224.58M | 248.8M | -79.88M | 34.54M | 1.7M |
Free Cash Flow | -132.48M | -78.95M | -45.68M | -29.82M | -13.75M |
Adj. Free Cash Flow | -159.16M | -90.35M | -47.21M | -30.49M | -14.86M |
Maintenance CapEx | n/a | -101.13K | n/a | -14K | -97K |
Growth CapEx | -134K | -132.87K | n/a | n/a | n/a |
Owner Earnings | -132.35M | -78.81M | -45.68M | -29.82M | -13.75M |
Add to Watchlist
Select watchlists to add or remove CGON